IMHOTEP, PJP, and more
This week's pod has lots of updates! IMHOTEP: Pre-operative doses of pembrolizumab lead to significant pCR rates in dMMR colon cancer. https...
Radio and PodcastLive Radio & Podcasts
Science & Medicine
OncoPharm
Oncology Pharmacist & Educator. Talking all things #oncopharm
OncoPharm Podcast Guide
Listen to OncoPharm, a Science & Medicine podcast by OncoPharmPod. Stream 427 episodes in English, follow new audio stories, and play episodes online on Radio and Podcast.
Show Topic
Browse this show under Science & Medicine podcasts.
Episodes
20 episodes are loaded now from a catalog of 427. More episodes can be opened from this page.
Discover More
Explore Science & Medicine podcasts, India podcasts and English podcasts.
Episodes
20 of 427 episodesVepdegestrant
The latest FDA drug approval is vepdegestrant, a heterobifunctional protein degrader, for ESR1 mutated breast cancer. We discuss what that a...
Targets Trop 2
This is our 1st in a series of podcasts/videos to role out once or twice a year on therapeutic targets in cancer. First up - Trop2 Check out...
Promising Pancreatic Cancer Data
This week we highlight some promising clinical research in the pancreatic cancer space. Daraxonrasib has shown OS benefit vs. chemo in the 2...
ICI-Induced T1DM
Bibliography: 1.. 2019 Systematic Review of Published Cases: https://doi.org/10.1111/dme.14050 2. Mass General Data & Publication: https://j...
Relacorilant
Discussing the new nab-paclitaxel adjunctive medication, relacorilant, for ovarian cancer. As a glucoCORticoid receptor antagonist, it is ha...
HOPA 2026 Recap
Recapping what I learned at HOPA 2026: -Beyond steroids for irAs -IT chemo beyond methotrexate and cytarabine -Pre-emptive CMV management in...
Nivo-AVD Approval
Nivolumab-AVD is finally approved for Hodgkin Lymphoma, and primary G-CSF prophylaxis is recommended (?) in the PI. Also, brief NOLA preview...
Tazemetostat Withdrawl and RECITE
Tazemetostat is withdrawn from the market due to a risk of secondary malignancies. RECITE asks if romiplostim improves platelet counts for p...
FDA Approval Updates Galore
Lots of FDA approval updates to discuss from the past few weeks: -Zongertinib gets approved in 1st line setting for ERBB2 TKD mutated metast...
BR.31 & ASCO GU '26
This week discuss BR.31 trial of adjuvant durvalumab in NSCLC and put it into the context of the positive studies with atezolizumab and pemb...
Rezatapopt and Colchicine for Trametnib/Dabrafenib Pyrexia
An exciting new drug, rezatapopt, may be effective in restoring p53 activity in cancers - a possible major therapeutic breakthrough. Can col...
Perioperative Enortumab vedotin + Pembrolizumab
The EV-303 trial that led to the FDA approval of perioperative enfortumab vedotin + pembrolizumab in cisplatin-ineligible bladder cancer pat...
Axi-Cel and 5-FU Label Changes
We have FDA changes to the labels of Axi-Cel (to allow for its use in primary CNS lymphoma) and 5-flourouracil (pre-treatment DPYD testing)....
Core Communication Skills in Chemotherapy Education
A brief discussion of the Core Communication Skills* and how to incorporate them into a chemotherapy education session. *Rapport Building *A...
PATINA
Reviewing the hot-off-the press publication of PATINA, palbociclib in HER-2 amplified breast cancer along with endocrine therapy and HER-2 t...
Sacituzumab govitecan + pembrolizumab and ASCO GI '26
We review the recent ASCENT-04/Keynote-D19 publication of sacituzuab govitecan + pembrolizumab for PD-L1 CPS of 10% and above TNBC compared...
Oncology Drug Use Evolution
This episode is the 2nd chapter in a broader presentation about putting together the puzzle pieces of oncology drug use. This chapter discus...
2025 New Drug Review
A Holiday tradition like few other. Are we keeping, regifting, or returning new oncology drugs approved in 2025?
Bladder Cancer Updates & SC Amivantamab
Are we nearing the end of the Platinum Era in bladder cancer? A press release suggests enfortumab vedotin + pembrolizumab in a perioperative...
Questions About OncoPharm
Where can I listen to OncoPharm episodes?
You can listen to OncoPharm episodes online on Radio and Podcast. Open an episode and the site player will stream the available audio.
What is OncoPharm about?
OncoPharm is listed as a Science & Medicine show. The show language is listed as English.
How many OncoPharm episodes are listed?
This page lists 427 episodes for OncoPharm. More episodes are available from the View more button when the list continues.